FRCPath (Fellow, Royal College of Pathologists, 2015)
FRCOphth (Fellow, Royal College of Ophthalmologists, 2012)
PhD (Newcastle University, 2005)
MRCOphth (Member, Royal College of Ophthalmologists, 2005)
MBBS (Honours with distinction, Newcastle University, 2002)
BMedSci (First class honours, Newcastle University, 2001)
North American Neuro-Ophthalmology Society (NANOS)
European Neuro-Ophthalmology Society (EUNOS)
British Isles Neuro-Ophthalmology Club (BINOC)
Association for Research in Vision and Ophthalmology (ARVO)
European Association for Vision and Eye Research (EVER)
British Eye Study Group (BESG)
UK Eye Genetics Group (UK EGG)
Current NHS / University Post
Professor of Ophthalmology, Department of Clinical Neurosciences, University of Cambridge
Associate Professor, Institute of Ophthalmology, University College London
Consultant Ophthalmologist, Cambridge Eye Unit, Addenbrooke’s Hospital, Cambridge
Consultant Ophthalmologist, Moorfields Eye Hospital NHS Foundation Trust, London
Medical training
Newcastle University
Neuro-Ophthalmology Fellowship
Emory Eye Center (Atlanta, Georgia)
Wilmer Eye Institute, John Hopkins (Baltimore, Maryland)
Research interest / experience
Professor Yu Wai Man is an academic neuro-ophthalmologist with a major research interest in optic neuropathies, neurogenetics & mitochondrial eye diseases.
Through affiliations in Cambridge, Newcastle & London, he has built a national referral network for the investigation & management of patients with mitochondrial eye diseases, particularly optic neuropathies & chronic progressive external ophthalmoplegia.
His research programme is currently focused on dissecting the molecular genetic basis of this group of disorders & the development of effective therapies, including novel gene therapy & stem cell approaches.
Professor Yu Wai Man is the author of over 200 peer-reviewed scientific publications in the field of neuro-ophthalmology, genetics & mitochondrial diseases.
Languages spoken
EnglishÂ
French
Contact Professor Patrick Yu Wai Man
Please note that new patients are required to have a medical referral at enquiry stage.